Oct 10, 2019
Data to be Presented at AASLD 2019 Shows HighTide Lead Compound Improves NASH in Two Animal Models
Oct 03, 2019
Akero Therapeutics and InSphero partner to evaluate AKR-001 using InSphero's 3D InSight(TM) Human Liver Disease platform
Oct 03, 2019
Zydus Announces Positive Results From EVIDENCES IV Phase 2 Clinical Trial of Saroglitazar Magnesium in NAFLD and NASH
Sep 26, 2019
Galmed Pharmaceuticals Initiated ARMOR, a Phase 3/4 Registrational Study of Aramchol in Subjects With NASH and Fibrosis
Sep 24, 2019
PharmaNest Launches FibroNest, the First Multivendor Image Analysis and Translational Platform for the Assessment of the Severity and Progression of Fibrosis in NASH
Aug 27, 2019
Ascletis Received IND Approval for its NASH Drug
Aug 08, 2019
89bio Initiates Phase 1b/2a Proof of Concept Clinical Trial of Investigational Therapy BIO89-100 for the Treatment of NASH
Aug 05, 2019
3-V Biosciences Changes Name to Sagimet Biosciences and Closes $25 Million Financing
Jul 29, 2019
Galmed Pharmaceuticals to Report Second Quarter 2019 Financial Results and Provide Business Update on Monday, August 5
Jul 02, 2019
HighTide Therapeutics Expands Leadership Team with Appointment of Adrian M. Di Bisceglie, M.D., as Chief Medical Officer
Jun 17, 2019
Zydus Announces Completion of Enrolment in EVIDENCES IV Phase 2 Clinical Trial of Saroglitazar Magnesium in NASH
Jun 11, 2019
NASH kNOWledge Joins Global International Nonalcoholic Steatohepatitis (NASH) DAY to Raise Disease Awareness
Jun 09, 2019
VeroScience Presents New Pipeline Data for Metabolic Disease Therapies at 2019 American Diabetes Association Meeting
May 30, 2019
Scientists Bioengineer Human Liver Disease in the Lab to Find New Treatments
May 22, 2019
Scientists Identify New Therapeutic Target for Fatty Liver Disease
Apr 30, 2019
Galmed Pharmaceuticals to Report First Quarter 2019 Financial Results and Provide Business Update on Tuesday, May 7
Apr 24, 2019
The Rising Crisis: How America´s Lifestyle Pushes it to the Verge of a Liver Disease Epidemic
Apr 18, 2019
Bioclinica Launches NAFLD/NASH Clinical Trials Practice
Apr 11, 2019
89bio Announces Preclinical Data That Demonstrate Potential Utility of BIO89-100 for Treatment of NASH
Apr 10, 2019
Second Edition Textbook, 'Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease,' Provides Roadmap for Preclinical and Clinical Research